chr5-110739114-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_138773.4(SLC25A46):c.-6G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000241 in 1,545,618 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 1 hom. )
Consequence
SLC25A46
NM_138773.4 5_prime_UTR
NM_138773.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.733
Genes affected
SLC25A46 (HGNC:25198): (solute carrier family 25 member 46) This gene encodes a mitochondrial solute carrier protein family member. It functions in promoting mitochondrial fission, and prevents the formation of hyperfilamentous mitochondria. Mutation of this gene results in neuropathy and optic atrophy. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 5-110739114-G-A is Benign according to our data. Variant chr5-110739114-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3043548.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC25A46 | NM_138773.4 | c.-6G>A | 5_prime_UTR_variant | 1/8 | ENST00000355943.8 | ||
SLC25A46 | NM_001303249.3 | c.-6G>A | 5_prime_UTR_variant | 1/8 | |||
SLC25A46 | NM_001303250.3 | c.10+867G>A | intron_variant | ||||
SLC25A46 | NR_138151.2 | n.108G>A | non_coding_transcript_exon_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC25A46 | ENST00000355943.8 | c.-6G>A | 5_prime_UTR_variant | 1/8 | 1 | NM_138773.4 | P1 | ||
SLC25A46 | ENST00000447245.6 | c.-6G>A | 5_prime_UTR_variant | 1/8 | 2 | ||||
SLC25A46 | ENST00000513807.5 | c.-204+867G>A | intron_variant | 2 | |||||
SLC25A46 | ENST00000508781.5 | n.112+867G>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152148Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
32
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000332 AC: 49AN: 147672Hom.: 1 AF XY: 0.000366 AC XY: 29AN XY: 79202
GnomAD3 exomes
AF:
AC:
49
AN:
147672
Hom.:
AF XY:
AC XY:
29
AN XY:
79202
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000245 AC: 341AN: 1393470Hom.: 1 Cov.: 31 AF XY: 0.000276 AC XY: 190AN XY: 687400
GnomAD4 exome
AF:
AC:
341
AN:
1393470
Hom.:
Cov.:
31
AF XY:
AC XY:
190
AN XY:
687400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000210 AC: 32AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74328
GnomAD4 genome
AF:
AC:
32
AN:
152148
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC25A46-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 14, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at